An overview of current and emerging devices for percutaneous left atrial appendage closure.
Atrial fibrillation
Left atrial appendage closure
Stroke prevention
Transcatheter
Journal
Trends in cardiovascular medicine
ISSN: 1873-2615
Titre abrégé: Trends Cardiovasc Med
Pays: United States
ID NLM: 9108337
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
16
05
2018
revised:
30
07
2018
accepted:
18
08
2018
pubmed:
13
9
2018
medline:
29
5
2019
entrez:
13
9
2018
Statut:
ppublish
Résumé
Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoagulant (OAC) therapy has been the main strategy for stroke prevention in AF patients; however, OAC therapy carries a bleeding risk and is not tolerated by all patients. Left atrial appendage (LAA) closure offers a non-pharmacological alternative for stroke prevention in patients with non-valvular AF. In this update, an overview of current and emerging LAA occluders is given - with special attention to the key design features of every single device and, if available, preclinical or clinical data.
Identifiants
pubmed: 30205924
pii: S1050-1738(18)30174-9
doi: 10.1016/j.tcm.2018.08.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
228-236Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.